Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome

被引:24
|
作者
Chen, An [1 ,2 ]
Lan, Zirong [1 ,2 ]
Li, Li [3 ]
Xie, Luting [1 ,2 ]
Liu, Xiaoyu [1 ,2 ]
Yang, Xiulin [1 ,2 ]
Wang, Siyi [1 ,2 ]
Liang, Qingchun [4 ]
Dong, Qianqian [1 ,2 ]
Feng, Liyun [1 ,2 ]
Li, Yining [1 ,2 ]
Ye, Yuanzhi [1 ,2 ]
Fu, Mingwei [1 ,2 ]
Lu, Lihe [5 ]
Yan, Jianyun [1 ,2 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Heart Ctr, Dept Cardiol,Lab Heart Ctr, 253 Ind Ave, Guangzhou 510280, Peoples R China
[2] Guangdong Prov Biomed Engn Technol Res Ctr Cardio, Guangdong Prov Key Lab Cardiac Funct & Microcircu, 253 Ind Ave, Guangzhou 510280, Peoples R China
[3] Jinan Univ, Guangzhou Red Cross Hosp, Dept Cardiol, 396 Tongfu Middle Rd, Guangzhou 510220, Peoples R China
[4] Southern Med Univ, Affiliated Hosp 3, Dept Anesthesiol, 183 West Zhongshan Ave, Guangzhou 510630, Peoples R China
[5] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Pathophysiolgy, 74 Zhongshan Er Rd, Guangzhou 510080, Peoples R China
基金
中国国家自然科学基金;
关键词
Canagliflozin; Vascular calcification; Vascular smooth muscle cell; Chronic kidney disease; NLRP3; SGLT2; INHIBITORS; KIDNEY; DAPAGLIFLOZIN; DYSFUNCTION; ACTIVATION;
D O I
10.1093/cvr/cvad119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Vascular calcification (VC) is prevalent in pathological processes such as diabetes, chronic kidney disease (CKD), and atherosclerosis, but effective therapies are still lacking by far. Canagliflozin (CANA), a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes mellitus and exhibits beneficial effects against cardiovascular disease. However, the effect of CANA on VC remains unknown. In this study, we hypothesize that CANA protects against VC. Methods and results Micro-computed tomography analysis and alizarin red staining revealed that CANA treatment prevented aortic calcification in CKD rats and in VitD3-overloaded mice. Moreover, CANA alleviated the calcification of rat and human arterial rings. Alizarin red staining revealed that calcification of rat and human vascular smooth muscle cells (VSMCs) was attenuated by CANA treatment and this phenomenon was confirmed by calcium content assay. In addition, CANA downregulated the expression of osteogenic differentiation markers Runx2 and BMP2. Of interest, qPCR and western blot analysis revealed that CANA downregulated the expression of the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3), and the downstream signalling molecules Caspase-1 and IL-1 beta in VSMCs as well. Both NLRP3 inhibitor MCC950 and knockdown of NLRP3 by siRNA independently resulted in decreased calcification of VSMCs. By contrast, activation of NLRP3 exacerbated VSMC calcification, and this effect was prevented by the addition of CANA. Conclusions Our study for the first time demonstrates that CANA exerts a protective effect on VC at least partially via suppressing the NLRP3 signalling pathway. Therefore, supplementation of CANA as well as inhibition of NLRP3 inflammasome presents a potential therapy for VC. [GRAPHICS] .
引用
收藏
页码:2368 / 2381
页数:14
相关论文
共 49 条
  • [31] Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice
    Dong, Liang
    Zhu, Yu-Hang
    Liu, De-Xing
    Li, Juan
    Zhao, Peng-Cheng
    Zhong, Yuan-Ping
    Chen, Yong-Qin
    Xu, Wei
    Zhu, Zhao-Qiong
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [32] Tamarixetin ameliorates cerebral ischemia-reperfusion injury via suppressing nicotinamide adenine dinucleotide phosphate oxidase 2/nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3 inflammasome activation
    Yang, Yanqiu
    Wang, Feng
    Fang, Mingxia
    Yao, Xiaohu
    Xu, Libin
    Liu, Yueyang
    Liu, Yeshu
    Liang, Dong
    Zeng, Kewu
    Li, Ning
    Hou, Yue
    PHYTOTHERAPY RESEARCH, 2024, 38 (08) : 4286 - 4306
  • [33] Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1 via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients
    Ruscitti, P.
    Cipriani, P.
    Di Benedetto, P.
    Liakouli, V.
    Berardicurti, O.
    Carubbi, F.
    Ciccia, F.
    Alvaro, S.
    Triolo, G.
    Giacomelli, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (01): : 35 - 44
  • [34] Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death
    McCall, Samuel H.
    Sahraci, Mahnaz
    Young, Amy B.
    Worley, Charles S.
    Duncan, Joseph A.
    Ting, Jenny Pan-Yun
    Marriott, Ian
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (01) : 30 - 40
  • [35] Galangin attenuates cadmium-evoked nephrotoxicity: Targeting nucleotide-binding domain-like receptor pyrin domain containing 3 inflammasome, nuclear factor erythroid 2-related factor 2, and nuclear factor kappa B signaling
    Salama, Samir A.
    Abd-Allah, Gamil M.
    Gad, Hesham S.
    Kabel, Ahmed M.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36 (07)
  • [36] Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling
    Zhao, Yu
    Li, Li
    Lu, Zongshi
    Hu, Yingru
    Zhang, Hexuan
    Sun, Fang
    Li, Qiang
    He, Chengkang
    Shu, Wentao
    Wang, Lijuan
    Cao, Tingbing
    Luo, Zhidan
    Yan, Zhencheng
    Liu, Daoyan
    Gao, Peng
    Zhu, Zhiming
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (15):
  • [37] Bushen Huoxue Recipe Inhibits Renal Fibrosis by Regulating the Reactive Oxygen Species/Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain-Containing 3-Induced Pyroptosis Pathway
    Chen, Xian
    Lu, Jianrao
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2023, 13 (02) : 241 - 249
  • [38] Glucose-Insulin-Potassium Alleviates Intestinal Mucosal Barrier Injuries Involving Decreased Expression of Uncoupling Protein 2 and NLR Family-Pyrin Domain-Containing 3 Inflammasome in Polymicrobial Sepsis
    Zhang, Jun-liang
    Chen, Yi-ting
    Chen, Guang-dao
    Wang, Tao
    Zhang, Ju-xin
    Zeng, Qi-yi
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [39] The Nucleotide-Binding Domain and Leucine-Rich Repeat Protein-3 Inflammasome Is Not Activated in Airway Smooth Muscle Upon Toll-Like Receptor-2 Ligation
    Hirota, Jeremy A.
    Im, Hanna
    Rahman, Mostafizur M.
    Rumzhum, Nowshin N.
    Manetsch, Melanie
    Pascoe, Chris D.
    Bunge, Kristin
    Alkhouri, Hatem
    Oliver, Brian G.
    Ammit, Alaina J.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2013, 49 (04) : 517 - 524
  • [40] Association of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 polymorphisms with systemic lupus erythematosus disease activity and biomarker levels A case-control study in Chinese population
    Su, Zhenzhen
    Niu, Qian
    Huang, Zhuochun
    Yang, Bin
    Zhang, Junlong
    MEDICINE, 2020, 99 (35)